Items related to Adjuvant Therapies and Markers of Post-Surgical Minimal...
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I: Markers and General Problems of Cancer Adjuvant Therapies (Recent Results in Cancer Research, 67) - Softcover
P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication of surgery-radiotherapy combinations that maximally decreased the incidence of local and regional relapses in sites that were within their reach. Today, the practice of clinical oncology is unthinkable without the active participation of the medical oncologist. He is the "third man" of the clinical oncology team, and he has recently focused attention on the fact that most relapses arise from distant metastases due to the proliferation of cells seeded there after having left the primary tumor site at the time of operation and, hence, are inaccessible to any form oflocal and/or regional treatment. On this evidence, medical oncologists have proposed the application of medical treatments for disseminated minimal residual disease (MRD). They have two available means: chemother apy and immunotherapy. Medical oncologists in general can be divided into three groups: chemotherapists, immunotherapists, and chemoimmunotherapists. The pure chemotherapists, who had already cured some malignant neoplasias such as Hodgkin's disease, acute lymphoid leukemia, placental choriocarcinoma, and Wilms' tumor, thought they might have the means of attacking the residual disease of common cancers.
"synopsis" may belong to another edition of this title.
- PublisherSpringer
- Publication date2011
- ISBN 10 3642813224
- ISBN 13 9783642813221
- BindingPaperback
- Number of pages172
Buy New
Learn more about this copy
US$ 106.16
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I: Markers and General Problems of Cancer Adjuvant Therapies (Recent Results in Cancer Research) [Soft Cover ]
Seller:
Rating
Book Description Soft Cover. Condition: new. Seller Inventory # 9783642813221
Buy New
US$ 106.16
Convert currency
Stock Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I: Markers and General Problems of Cancer Adjuvant Therapies (Recent Results in Cancer Research, 67)
Published by
Springer
(2011)
ISBN 10: 3642813224
ISBN 13: 9783642813221
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020237023
Buy New
US$ 115.80
Convert currency
Seller Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I
Published by
Springer Berlin Heidelberg Dez 2011
(2011)
ISBN 10: 3642813224
ISBN 13: 9783642813221
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication of surgery-radiotherapy combinations that maximally decreased the incidence of local and regional relapses in sites that were within their reach. Today, the practice of clinical oncology is unthinkable without the active participation of the medical oncologist. He is the 'third man' of the clinical oncology team, and he has recently focused attention on the fact that most relapses arise from distant metastases due to the proliferation of cells seeded there after having left the primary tumor site at the time of operation and, hence, are inaccessible to any form oflocal and/or regional treatment. On this evidence, medical oncologists have proposed the application of medical treatments for disseminated minimal residual disease (MRD). They have two available means: chemother apy and immunotherapy. Medical oncologists in general can be divided into three groups: chemotherapists, immunotherapists, and chemoimmunotherapists. The pure chemotherapists, who had already cured some malignant neoplasias such as Hodgkin's disease, acute lymphoid leukemia, placental choriocarcinoma, and Wilms' tumor, thought they might have the means of attacking the residual disease of common cancers. 176 pp. Englisch. Seller Inventory # 9783642813221
Buy New
US$ 124.12
Convert currency
Stock Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I : Markers and General Problems of Cancer Adjuvant Therapies
Published by
Springer
(2011)
ISBN 10: 3642813224
ISBN 13: 9783642813221
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783642813221_lsuk
Buy New
US$ 137.23
Convert currency
Seller Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I
Published by
Springer Berlin Heidelberg
(2011)
ISBN 10: 3642813224
ISBN 13: 9783642813221
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. 1978 Annual Plenary Meeting of the European Organization for Treatment of Cancer, Paris, June 1978P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, . Seller Inventory # 5071361
Buy New
US$ 101.95
Convert currency
Stock Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I: Markers and General Problems of Cancer Adjuvant Therapies (Recent Results in Cancer Research)
Seller:
Rating
Book Description Paperback. Condition: Brand New. reprint edition. 176 pages. 9.50x6.60x0.70 inches. In Stock. Seller Inventory # x-3642813224
Buy New
US$ 145.20
Convert currency
Seller Image
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I : Markers and General Problems of Cancer Adjuvant Therapies
Published by
Springer Berlin Heidelberg
(2011)
ISBN 10: 3642813224
ISBN 13: 9783642813221
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication of surgery-radiotherapy combinations that maximally decreased the incidence of local and regional relapses in sites that were within their reach. Today, the practice of clinical oncology is unthinkable without the active participation of the medical oncologist. He is the 'third man' of the clinical oncology team, and he has recently focused attention on the fact that most relapses arise from distant metastases due to the proliferation of cells seeded there after having left the primary tumor site at the time of operation and, hence, are inaccessible to any form oflocal and/or regional treatment. On this evidence, medical oncologists have proposed the application of medical treatments for disseminated minimal residual disease (MRD). They have two available means: chemother apy and immunotherapy. Medical oncologists in general can be divided into three groups: chemotherapists, immunotherapists, and chemoimmunotherapists. The pure chemotherapists, who had already cured some malignant neoplasias such as Hodgkin's disease, acute lymphoid leukemia, placental choriocarcinoma, and Wilms' tumor, thought they might have the means of attacking the residual disease of common cancers. Seller Inventory # 9783642813221
Buy New
US$ 124.02
Convert currency